公司新闻

Duesseldorf, November 23, 2021 – Gerresheimer AG has reached another milestone in the realization of its financing strategy by successfully issuing a…

Gerresheimer’s first own IP autoinjector suitable for both small and large molecules enhances broad portfolio of solutions, medical devices and…

Core business revenue shows third-quarter organic growth of 9.8 % Strategic positioning as innovative provider of biotech, pharma and beauty…

Duesseldorf, September 9, 2021 – At its most recent meeting, the Supervisory Board of Gerresheimer AG prematurely extended the contract of Chief…

Duesseldorf, August 31, 2021. Gerresheimer has launched a new part of their webpage dedicated to cosmetic packaging. The new pages convey a fresh look…

Organic Group revenue growth of 7.5 %, and 7.1 % in core business Solutions for biotech drugs and high-value solutions continue to drive revenues…

Duesseldorf, June 9, 2021 - The virtual Annual General Meeting of Gerresheimer AG has approved the payment of a dividend of EUR 1.25 per share. “All…

Organic revenue growth of 3.1 % in core business Strong development in High Value Solutions: Focus on Biological Solutions pays off Adjusted…

Düsseldorf, March 31, 2021. Ambitious targets will direct Gerresheimer's sustainability strategy in the coming years. Among other things, the company…